PepFinder
tumor-targeting peptideCancer Research Peptides

LHRH (Gonadotropin analog for targeting)

LHRH agonist peptides used as carrier molecules to target LHRH receptors expressed in ~80% of endometrial, ovarian, and prostate cancers. AEZS-108 (AN-152) is a cytotoxic LHRH-doxorubicin conjugate in trials.

tumor-targetingdrug-deliveryhormone-receptorovarian-cancerprostate-cancer
3D Structure
3D Structure
1182.24 Da
Molecular Weight1,182.24 Da
FormulaC55H75N17O13
PubChem CID36523
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity59274589810511205m/z1182.6
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

LHRH agonist peptides used as carrier molecules to target LHRH receptors expressed in ~80% of endometrial, ovarian, and prostate cancers. AEZS-108 (AN-152) is a cytotoxic LHRH-doxorubicin conjugate in…